UNKNOWNPhase 4

Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy

The investigators evaluate the effects of a subanesthetic dose of ketamine, administered as an adjunct to sevoflurane, on duration of seizure activity, hemodynamic profile and recovery times during electroconvulsive therapy (ECT) in patients with major depression.

Sponsor

Inonu University

Enrollment

60 participants

Sites

1 locations

Start Date

July 2014

Completion

October 2014

Depressive DisorderSevofluraneKetamineSaline

Enrollment & Timeline

UNKNOWN

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

3 months

total trial span

Rate

pts/month needed

Jul 2014Month 143 of 3Oct 2014

100% of trial timeline elapsed

At 1 sites, each site needs to enroll approximately 20.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

seizure duration

During electroconvulsive therapy (30 minutes)

the time from application of the ECT stimulus to the cessation of tonic-clonic motor activity in the isolated arm.

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Ketofol in electroconvulsive therapy anesthesia: two stones for one bird.

Yalcin Saban, Aydoğan Harun, Selek Salih et al.Journal of anesthesia2012

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

UNKNOWNPhase 4

Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy

Sponsor

Inonu University

Enrollment

60 participants

Sites

1 locations

Start Date

July 2014

Completion

October 2014

Depressive DisorderSevofluraneKetamineSaline

Enrollment & Timeline

UNKNOWN

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

3 months

total trial span

Rate

pts/month needed

Jul 2014Month 143 of 3Oct 2014

100% of trial timeline elapsed

At 1 sites, each site needs to enroll approximately 20.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

seizure duration

During electroconvulsive therapy (30 minutes)

the time from application of the ECT stimulus to the cessation of tonic-clonic motor activity in the isolated arm.

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Ketofol in electroconvulsive therapy anesthesia: two stones for one bird.

Yalcin Saban, Aydoğan Harun, Selek Salih et al.Journal of anesthesia2012

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

all

Healthy Volunteers

View full criteria

Inclusion Criteria:

* Major depressive patients

Exclusion Criteria:

* Pregnancy
* Have a history of myocardial infarction in the previous six months
* Atrial fibrillation or flutter
* Heart block
* Unregulated hypertension
* Cerebrovascular diseases
* A known drug allergy

Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)